Patent details

Basic Information

Publication number:

EP3615052

PCT Application Number:

CN2018084417

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187915160

PCT Publication Number:

WO2018196782

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF HCN INHIBITORS FOR TREATMENT OF CANCER

French Title of Invention:

UTILISATION D'INHIBITEURS DE HCN POUR LE TRAITEMENT DU CANCER

German Title of Invention:

VERWENDUNG VON HCN-INHIBITOREN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

25/04/2018

Grant date:

25/01/2023

EP Publication Date:

04/03/2020

PCT Publication Date:

01/11/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/01/2023

EP B1 Publication Date:

25/01/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/04/2023

Expiration date:

25/04/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/01/2023

 

 

Name:

The University of Hong Kong

Address:

Pokfulam Road, Hong Kong, China (CN)

Inventor

1

Name:

KHOO, Ui Soon

Address:

China (CN)

2

Name:

TSOI, Ho Frankie

Address:

China (CN)

3

Name:

LEE, Kin Wah Terence

Address:

China (CN)

4

Name:

GONG, Chun Jade

Address:

China (CN)

Priority

Priority Number:

201762490774 P

Priority Date:

27/04/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 31/55; A61K 31/7088; C12N 15/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202304

Publication date:

25/01/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages